Streetbeat News

Partnerships

AGEN

Agenus Inc. announced that the Cancer Therapy Evaluation Program (CTEP) is accepting Letters of Intent (LOIs) for clinical studies using botensilimab, an anticancer agent developed in collaboration with Agenus. CTEP will also consider supplying botensilimab for nonclinical studies.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:35 am

ELEV

GSK

LLY

Elevation Oncology plans to expand its Phase 1 trial to include two combination cohorts evaluating EO-3021 for advanced gastric or gastroesophageal junction cancer. The company expects to initiate dosing by the end of 2024, following clinical supply agreements with Eli Lilly and GSK.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:32 am

CCG

Cheche Group has formed a strategic partnership with BAIC Group's insurance provider. This collaboration aims to enhance insurance services and expand market reach.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:31 am

VIGL

Vigil Neuroscience shares are trading higher after Sanofi made a $40 million investment in the company.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:29 am

AES

AES has announced a strategic partnership with an AI fund to accelerate the energy transition using artificial intelligence. This collaboration aims to enhance the efficiency and sustainability of energy solutions.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:27 am

OPTN

Optinose announced that its product Xhance (Fluticasone Propionate) has been added to Express Scripts' national formularies, including the National Preferred, Flex, and Basic Formularies.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:11 am

BABA

Alibaba.com has reaffirmed its commitment to supporting Micro, Small, and Medium Enterprises (MSMEs) by unveiling strategic plans aimed at diversifying its supplier network and enhancing trade opportunities.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:06 am

PLTR

Voyager Space has announced a strategic partnership with Palantir to integrate Palantir's AI capabilities into their defense solutions. This partnership aims to advance the space and defense technology sectors, leveraging Palantir's expertise with the Department of Defense.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:04 am

SFTBF

TEM

SoftBank Group Corp (OTC:SFTBF) and Tempus AI Inc (NASDAQ:TEM) have announced a joint venture, SB TEMPUS Corp., to enhance precision medicine in Japan using AI. The venture, launching in July 2024, aims to revolutionize cancer treatment by leveraging Tempus' AI technology. Both companies will invest JPY 15.0 billion each. Tempus also received FDA clearance for its AI-driven ECG-AF device.

Portfolio Pulse from Shivani Kumaresan

June 27, 2024 | 10:50 am

AMZN

Amazon has invested $72 million into its Indian payments business to compete with Google Pay and Walmart-backed PhonePe. This brings Amazon's total investment in the platform to $113.8 million this year. The move aims to strengthen Amazon's position in India's rapidly growing digital payments market.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 10:19 am